November 2025 in “Journal of Clinical Medicine” The researchers reported that baricitinib treatment for at least 52 weeks reduced severe alopecia areata severity and improved psychological well-being and quality of life in study participants.
October 2025 in “University of Zadar Institutional Repository” This article reviews the association between androgenic alopecia and metabolic syndrome, highlighting the importance of early diagnosis and lifestyle changes to manage associated health risks, but reports no new clinical results.
September 2025 in “PubMed” In this study, researchers observed diffuse hair loss in Japanese patients post-hematopoietic stem cell transplantation and chemotherapy, with treatments targeting hair follicle miniaturization, like topical minoxidil, improving hair volume in about 52.9% of cases.
September 2025 in “IP Indian Journal of Clinical and Experimental Dermatology” Results are not reported in this abstract, which focuses on promoting the offerings of a medical publisher in Delhi, India, including open access and print journals across various medical disciplines.
September 2025 in “PubMed” In this study, the combined use of Exosome Regenerative Complex and RF microneedling significantly improved hair density, hair growth, and hair quality in subjects with self-perceived thinning hair, showing high satisfaction with no adverse events after 120 days of treatment.
September 2025 in “Acta Medica International” In this study, a triple wavelength laser was found to be highly effective and well-tolerated for reducing hair in Indian women with Fitzpatrick skin types III and IV, achieving an average hair count reduction of 86.5%, with only mild and transient adverse effects observed.
August 2025 in “Archives of Dermatological Research” In this randomized controlled trial, oral minoxidil at 2.5 mg daily was more effective than topical minoxidil for increasing hair thickness, counts, and density in men with androgenetic alopecia, demonstrating more significant improvements and better compliance over six months.
July 2025 in “Frontiers in Medicine” In this systematic review and meta-analysis, the authors examined single-spin versus double-spin centrifugation protocols for PRP in patients with androgenic alopecia and found no significant difference in platelet concentration, hair density, or hair types between the protocols.
July 2025 in “Actas Dermo-Sifiliográficas” This study found that a single session of botulinum toxin, whether administered subcutaneously or combined intramuscularly and subcutaneously, did not significantly improve hair density or hair quality in men with androgenetic alopecia after six months.
July 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” This study found no significant differences in platelet concentration or hair growth outcomes between single-spin and double-spin PRP centrifugation methods for treating androgenic alopecia, suggesting that the simpler single-spin approach may be preferable.
July 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” In this systematic review and meta-analysis, the researchers found no significant difference in platelet concentration, hair density improvement, or changes in terminal and vellus hair rates between single-spin and double-spin PRP centrifugation protocols in treating androgenic alopecia.
July 2025 in “Journal of Dermatological Treatment” This study found that platelet-rich plasma significantly improved hair growth parameters in androgenic alopecia patients and was even more effective when combined with minoxidil, particularly in reducing vellus hair.
July 2025 in “International Journal of Trichology” This study reported six pediatric cases of temporal triangular alopecia and highlighted the use of trichoscopy to distinguish it by detecting a distinctive carpet of vellus hair, helping to differentiate TTA from other hair loss conditions.
July 2025 in “INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH” In this observational study, researchers found that alopecia areata is associated with specific trichoscopic features, such as black dots, yellow dots, and vellus hair, and highlighted trichoptilosis as a potential overlap feature with other hair disorders, suggesting a need for further differentiation between these conditions.
June 2025 in “British Journal of Dermatology” This study found that specific dermoscopic markers, including yellow dots and black dots, are associated with poor prognosis in alopecia areata patients, while vellus hair indicates a more favorable outcome.
This study involved using smartphone applications and low-cost trichoscopy devices to assess various hair and scalp conditions, with diagnoses confirmed through detailed imaging during remote consultations and in-person evaluations.
May 2025 in “Apollo Medicine” This study found that trichoscopy can be a helpful, noninvasive tool for identifying specific patterns that correlate with the clinical activity and severity of alopecia areata, enhancing its diagnosis and monitoring.
This case study highlights rose stem cell-derived exosomes combined with thulium laser therapy as a promising treatment for stress-induced alopecia areata, achieving significant hair regrowth and pigmentation without corticosteroid side effects, though further research is needed for broader application.
The researchers observed that in cases of alopecia areata with atypical features, histopathological confirmation may be necessary, as trichoscopic clues like loss of follicle ostia and vellus hairs were common, while typical features such as exclamation mark hairs were not always present.
April 2025 in “Archives of Dermatological Research” In this study, microneedling-administered topical cetirizine was observed to significantly enhance hair density and increase vellus hair prevalence in men with androgenetic alopecia, with no notable adverse effects reported.
February 2025 in “Archives of Dermatological Research” Combining PRP with topical minoxidil is most effective for hair growth in androgenetic alopecia.
January 2025 in “Journal of Contemporary Medical Practice” The researchers reported that nano-cerium oxide improved androgenetic alopecia in mice by increasing the ratio of terminal to vellus hairs, elevating IGF-1 expression, and reducing TGF-β and DHT levels in the skin, suggesting potential for drug development.
January 2025 in “Dermatology Practical & Conceptual” Perinevoid alopecia can be effectively treated with non-invasive corticosteroids.
January 2025 in “International Journal of Trichology” This study found both topical spironolactone and topical minoxidil to be effective and safe treatments for female pattern hair loss, with mild to marked improvement observed over six months in both treatment groups, though more side effects were noted with minoxidil.
January 2025 in “International Journal of Medical Arts” This study found that a topical 1.0% sildenafil citrate solution significantly increased vellus and terminal hairs in women with female pattern hair loss without affecting hair thickness, suggesting it may be a promising treatment option.
This study highlights the use of dermatoscopy as a valuable tool for diagnosing and monitoring alopecia areata, noting that specific hair shaft alterations such as exclamation-mark hairs and black dots are indicators of active disease, while vellus hairs signal early regrowth.
January 2025 in “NATIONAL BOARD OF EXAMINATIONS JOURNAL OF MEDICAL SCIENCES” This case series reports the specific dermoscopic features observed in two patients with syphilitic alopecia, highlighting alopecic patches with empty hair follicles and other distinguishing characteristics that may aid in differentiating it from other hair disorders.
January 2025 in “Surgical & Cosmetic Dermatology” This article reviews temporal triangular alopecia, emphasizing the utility of dermoscopy for diagnosis, and reports no new clinical treatment findings.
January 2025 in “Mansoura Medical Journal” This study found that topical minoxidil 5% was more effective than cetirizine 1% in improving hair parameters in male androgenetic alopecia, though cetirizine showed promising safety and some efficacy.
December 2024 in “http://isrctn.com/” MpowerTM may improve hair growth and satisfaction more than plain minoxidil, with mild side effects.